Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00073918
Status:
COMPLETED
Last Update Posted:
2017-08-18
First Post:
2003-12-10
Brief Title:
Iodine I 131 Tositumomab Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkins Lymphoma
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Fred Hutchinson Cancer Center
Organization Data
Organization:
Fred Hutchinson Cancer Center
Class:
OTHER
Study ID:
136800
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fred Hutchinson Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
Ajay Gopal
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Fred Hutchinson Cancer Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |